Obermatt
See Similar Stocks →

Medifast

NYQ:MED · US58470H1014
Personal ProductsSmall

360

20
EV / EBIT100
Price / Owner Earnings89
Owner Earnings Yield1
Dividend Yield1
Price/Sales72
Price/Book79
Return on Capital7
Cash Return on Capital16
Return on Equity12
EBIT Margin10
Gross Profitability93
Accruals49
Owner Earnings Margin16
Sales growth3
Profit Growth11
Long-Term EPS Growth6
Owner Earnings Growth4
Reinvestment94
Price momentum67
Debt load83
Refinancing24
Debt Payback1
Liquidity94
Analyst ratings18
Opinion Changes50
Price Target Upside16
Market mood4
Value Creation0/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Medifast doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryPersonal Products
SizeSmall
TypePublic Company
ExchangeNYSE
Founded1980
Employees465
Websitemedifastinc.com
ISINUS58470H1014
Last UpdateApr 2, 2026
Index & Theme
ObesityNutraceuticalDigital WellnessLifestyleWellness and RecoveryFitnessHealth CareWellness

Description

Medifast, Inc. (Medifast) operates as a health and wellness company. The company offers a simple, yet comprehensive approach to achieving optimal metabolic health and well-being by empowering individuals to make lasting changes. The company’s scient…

Analysis

Weak and unloved

Medifast, Inc. is weak and unloved: below-average business metrics and a price that reflects that disappointment.

Valuation data is not available for this company.

The trajectory is tepid and the balance sheet is adequate. The company scores 0/20 on our value-creation score: not creating value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
26
2023202420252026

All-time high

100

Jan 2023

All-time low

26

Mar 2026

Average rank

48

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
72
87
69
65
Price/Earnings
88
5
97
93
Price/Book
79
87
25
15
Dividend Yield
1
1
100
97
Value (overall)
79
44
82
77

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Medifast with its peers
Hims & Hers Health
NYQ:HIMS
3
CountryUSA
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Bioharvest Sciences
MUN:8MV0
19
CountryCanada
IndustryPersonal Products
SizeSmall
Full Stock Analysis →
FitLife Brands
NAQ:FTLF
38
CountryUSA
IndustryPersonal Products
SizeSmall
Full Stock Analysis →
Nature's Sunshine
NAQ:NATR
94
CountryUSA
IndustryPersonal Products
SizeMedium
Full Stock Analysis →
USANA Health Sciences
NYQ:USNA
96
CountryUSA
IndustryPersonal Products
SizeMedium
Full Stock Analysis →
PetMed Express
NSQ:PETS
52
CountryUSA
IndustrySpecialty Retail
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →